Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole for recurrence of intestinal metaplasia in Barrett's esophagus
NCT02162758Phase 2Terminated
- Sponsor
- Takeda
- Start
- Jul 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexlansoprazole in Barrett's esophagus, sponsored by Takeda. Started Jul 2014; status: terminated.
02
Drugs
dexlansoprazole
03
Conditions
Barrett's esophagus
Beyond the preview
Go deeper on NCT02162758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02162758.